Softwr

Healthcare · head to head

Meru Health vs Techcyte

Meru Health logo

Meru Health

Healthcare

Twelve week therapist led mental health programme combining an app, a clinician and HRV biofeedback

From
On request
Rated
-
Full reviewWebsite
Techcyte logo

Techcyte

Healthcare

AI digital pathology across clinical, veterinary and environmental laboratory disciplines

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Meru Health the programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.; Techcyte regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
  • They diverge on capability: Meru Health covers Twelve week structured programme, Techcyte covers Fusion Parasitology Suite.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Meru Health and Techcyte actually diverge.

Attributes where Meru Health and Techcyte differ
AttributeMeru HealthTechcyte
PlatformsWeb, iOS, AndroidWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Meru Health

  • Twelve week structured programme
  • Licensed therapist
  • Psychiatric consultation
  • HRV biofeedback device
  • Daily in app practice
  • Meru Health Advanced
  • Payer contracting
  • Outcome measurement

Only in Techcyte

  • Fusion Parasitology Suite
  • Cervical cytology
  • Haematology
  • Urinalysis
  • Bacteriology and mycology
  • Vetcyte
  • Scanner agnostic ingestion
  • Remote review

What people use each for

The jobs each tool is most often brought in to do.

Meru Health

  • A health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefitnot Techcyte
  • An employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathwaynot Techcyte
  • A member who needs medication review alongside therapy, which most app based mental health products cannot providenot Techcyte
  • A health system seeking to offload moderate depression and anxiety from a psychiatry service with long waitsnot Techcyte

Techcyte

  • A clinical laboratory that cannot recruit technologists for high volume manual parasitology screening and needs AI pre screening with human releasenot Meru Health
  • A veterinary reference laboratory processing large volumes of faecal and blood smears that wants Vetcyte to triage the normal casesnot Meru Health
  • A European laboratory that can deploy the CE marked products clinically, which is where Techcyte regulatory position is strongestnot Meru Health
  • An environmental testing laboratory needing consistent microscopy classification across analysts and sitesnot Meru Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Meru Health

  • The programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.
  • Whether the employer, the health plan or the member pays depends on the contract route, and members frequently do not know which applies to them until they receive a bill or discover they do not.
  • A structured programme demands daily engagement, and members who cannot sustain that get much less than the outcome data implies, because the published results reflect members who completed.
  • The heart rate variability device is a differentiator but also a logistics and support burden, adding shipping, returns and device support to what would otherwise be a software deployment.
  • Meru is small relative to Lyra, Spring Health and the large payer owned behavioural health offerings, so an employer choosing it takes on more vendor concentration risk in a category that has seen frequent consolidation.

Techcyte

  • Regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
  • Slide scanning for parasitology, haematology and cytology needs multi plane imaging that a histology scanner may not produce, so a laboratory that already owns a scanner often has to buy new hardware, which becomes the biggest line in the project.
  • Each discipline is licensed separately, so a laboratory wanting parasitology, urinalysis and haematology assembles three modules and three validation studies rather than buying one platform.
  • AI pre screening does not remove the need for a qualified reviewer to release results, so the staffing saving is in review time per slide, not in headcount, and business cases that assume otherwise do not hold.
  • Techcyte covers a very wide set of disciplines, which means depth varies between them, and the maturity of a newer module is not the maturity of the parasitology or cytology products that made the company its name.

Pricing, plan by plan

Meru Health

On request
  • Meru Health$undefined/year
    • Contracted per completed programme or per member per month depending on buyer type
    • Health plan contracts bill differently from employer contracts
    • Member cost sharing depends on whether access comes via insurance or an employer benefit

Techcyte

On request
  • Techcyte$undefined/year
    • Priced per slide or per annual specimen volume by discipline
    • Each discipline module licensed separately
    • Slide scanning hardware bought separately, not included

Which should you pick?

Choose Meru Health if

  • You need twelve week structured programme.
  • You work on Web, iOS, Android.
  • You also want licensed therapist.
Meru Health review

Choose Techcyte if

  • You need fusion parasitology suite.
  • You also want cervical cytology.
Techcyte review

Questions people ask

Is Meru Health or Techcyte better?
Neither clearly leads. Meru Health starts at On request and Techcyte at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Meru Health or Techcyte?
Meru Health starts at On request and Techcyte at On request.
Does Meru Health or Techcyte run on more platforms?
Meru Health runs on Web, iOS, Android. Techcyte runs on Web.
What is Meru Health best used for?
Meru Health is most often used for a health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefit, an employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathway, a member who needs medication review alongside therapy, which most app based mental health products cannot provide, a health system seeking to offload moderate depression and anxiety from a psychiatry service with long waits. Of those, a health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefit and an employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathway are not what Techcyte is typically brought in for.
What can Meru Health do that Techcyte cannot?
Meru Health covers Twelve week structured programme, Licensed therapist, Psychiatric consultation, HRV biofeedback device. Techcyte covers Fusion Parasitology Suite, Cervical cytology, Haematology, Urinalysis.

Answered from the vendors’ own pages

Meru Health: Is Meru Health still operating?

Yes. It launched Meru Health Advanced in May 2026 and expanded its Harvard Pilgrim Health Care collaboration in 2025. It has not wound down.

Techcyte: Is Techcyte FDA cleared?

Not uniformly. Several United States offerings, including the Fusion Parasitology Suite, are labelled research use only and not for diagnostic use in the United States. Check the regulatory status of each specific module for your country before purchase.

Meru Health: How long is the programme?

Around twelve weeks. It is a bounded treatment episode rather than open ended therapy, which is why health plans will contract for it.

Techcyte: Can we use it clinically in Europe?

Techcyte solutions are CE marked and clinically deployed across Europe, which is where its regulatory position is strongest. Confirm the current certificate for the specific module.

Meru Health: Who pays?

It depends on the contract. Meru sells to both health plans and employers, and member cost sharing differs between those routes. Confirm which applies before enrolling.

Techcyte: Does it eliminate the need for a technologist?

No. AI pre screens and prioritises, but a qualified reviewer still releases results. The saving is in review time per slide.

Meru Health: Does it include medication?

Psychiatric consultation is part of the programme where medication is indicated, which distinguishes it from app plus coaching products that cannot prescribe.

Techcyte: Do we need a specific scanner?

Techcyte works with several scanner vendors, but disciplines such as parasitology and haematology need multi plane imaging that many histology scanners cannot produce, so confirm hardware compatibility early.

Share

Related pages

More on Meru Health

More on Techcyte

Keep looking

Other head to heads